| A regulatory B cell subset with a unique CD1dhiCD5+ phenotype controls T cell-dependent inflammatory responses K Yanaba, JD Bouaziz, KM Haas, JC Poe, M Fujimoto, TF Tedder Immunity 28 (5), 639-650, 2008 | 1536 | 2008 |
| Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression T Matsushita, K Yanaba, JD Bouaziz, M Fujimoto, TF Tedder The Journal of clinical investigation 118 (10), 3420-3430, 2008 | 1143 | 2008 |
| Connective tissue growth factor gene expression in tissue sections from localized scleroderma, keloid, and other fibrotic skin disorders A Igarashi, K Nashiro, K Kikuchi, S Sato, H Ihn, M Fujimoto, ... Journal of Investigative Dermatology 106 (4), 729-733, 1996 | 608 | 1996 |
| Idiopathic inflammatory myopathies IE Lundberg, M Fujimoto, J Vencovsky, R Aggarwal, M Holmqvist, ... Nature Reviews Disease Primers 7 (1), 86, 2021 | 474 | 2021 |
| Elevated serum levels of interleukin 4 (IL-4), IL-10, and IL-13 in patients with systemic sclerosis. M Hasegawa, M Fujimoto, K Kikuchi, K Takehara The Journal of rheumatology 24 (2), 328-332, 1997 | 425 | 1997 |
| Common and distinct clinical features in adult patients with anti-aminoacyl-tRNA synthetase antibodies: heterogeneity within the syndrome Y Hamaguchi, M Fujimoto, T Matsushita, K Kaji, K Komura, M Hasegawa, ... PloS one 8 (4), e60442, 2013 | 414 | 2013 |
| Altered blood B lymphocyte homeostasis in systemic sclerosis: expanded naive B cells and diminished but activated memory B cells S Sato, M Fujimoto, M Hasegawa, K Takehara Arthritis & Rheumatism: Official Journal of the American College of …, 2004 | 412 | 2004 |
| Regulatory B cells (B10 cells) have a suppressive role in murine lupus: CD19 and B10 cell deficiency exacerbates systemic autoimmunity R Watanabe, N Ishiura, H Nakashima, Y Kuwano, H Okochi, K Tamaki, ... The Journal of Immunology 184 (9), 4801-4809, 2010 | 392 | 2010 |
| Quantitative genetic variation in CD19 expression correlates with autoimmunity S Sato, M Hasegawa, M Fujimoto, TF Tedder, K Takehara The Journal of Immunology 165 (11), 6635-6643, 2000 | 390 | 2000 |
| Identification of a novel autoantibody reactive with 155 and 140 kDa nuclear proteins in patients with dermatomyositis: an association with malignancy K Kaji, M Fujimoto, M Hasegawa, M Kondo, Y Saito, K Komura, ... Rheumatology 46 (1), 25-28, 2007 | 385 | 2007 |
| Clinical correlations with dermatomyositis-specific autoantibodies in adult Japanese patients with dermatomyositis: a multicenter cross-sectional study Y Hamaguchi, M Kuwana, K Hoshino, M Hasegawa, K Kaji, T Matsushita, ... Archives of dermatology 147 (4), 391-398, 2011 | 369 | 2011 |
| Deep‐learning‐based, computer‐aided classifier developed with a small dataset of clinical images surpasses board‐certified dermatologists in skin tumour diagnosis Y Fujisawa, Y Otomo, Y Ogata, Y Nakamura, R Fujita, Y Ishitsuka, ... British Journal of Dermatology 180 (2), 373-381, 2019 | 358 | 2019 |
| Myositis‐specific anti‐155/140 autoantibodies target transcription intermediary factor 1 family proteins M Fujimoto, Y Hamaguchi, K Kaji, T Matsushita, Y Ichimura, M Kodera, ... Arthritis & Rheumatism 64 (2), 513-522, 2012 | 338 | 2012 |
| The diagnostic utility of anti-melanoma differentiation-associated gene 5 antibody testing for predicting the prognosis of Japanese patients with DM T Koga, K Fujikawa, Y Horai, A Okada, S Kawashiri, N Iwamoto, T Suzuki, ... Rheumatology 51 (7), 1278-1284, 2012 | 324 | 2012 |
| CD19-dependent B lymphocyte signaling thresholds influence skin fibrosis and autoimmunity in the tight-skin mouse E Saito, M Fujimoto, M Hasegawa, K Komura, Y Hamaguchi, Y Kaburagi, ... The Journal of clinical investigation 109 (11), 1453-1462, 2002 | 295 | 2002 |
| CD83 expression influences CD4+ T cell development in the thymus Y Fujimoto, LL Tu, AS Miller, C Bock, M Fujimoto, C Doyle, DA Steeber, ... Cell 108 (6), 755-767, 2002 | 287 | 2002 |
| Anti-NXP2 autoantibodies in adult patients with idiopathic inflammatory myopathies: possible association with malignancy Y Ichimura, T Matsushita, Y Hamaguchi, K Kaji, M Hasegawa, Y Tanino, ... Annals of the rheumatic diseases 71 (5), 710-713, 2012 | 286 | 2012 |
| CD19 regulates Src family protein tyrosine kinase activation in B lymphocytes through processive amplification M Fujimoto, Y Fujimoto, JC Poe, PJ Jansen, CA Lowell, AL DeFranco, ... Immunity 13 (1), 47-57, 2000 | 276 | 2000 |
| 239th ENMC international workshop: classification of dermatomyositis, Amsterdam, the Netherlands, 14–16 December 2018 AL Mammen, Y Allenbach, W Stenzel, O Benveniste, J De Bleecker, ... Neuromuscular Disorders 30 (1), 70-92, 2020 | 254 | 2020 |
| CD19 regulates skin and lung fibrosis via Toll-like receptor signaling in a model of bleomycin-induced scleroderma A Yoshizaki, Y Iwata, K Komura, F Ogawa, T Hara, E Muroi, M Takenaka, ... The American journal of pathology 172 (6), 1650-1663, 2008 | 251 | 2008 |
